Fresenius, DE0005785604

Fresenius stock heads into the open after a 0.4 percent fall

Published on 09/25/2026 at 07:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 24, 2026, Fresenius stock had fallen 0.4 percent on Xetra; European shares also declined as markets awaited US-China talks.

Fresenius SE – Fotorealistisch: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht
Fresenius SE & Co. KGaA (ISIN DE0005785604) ist ein internationaler Gesundheitskonzern mit Sitz in Bad Homburg. Das Unternehmen betreibt Krankenhäuser und entwickelt Arzneimittel und Infusionslösungen. Dieses Bild zeigt: Modernes Krankenhauszimmer mit Patientenmonitor bei Tageslicht, Illustration mit AI erstellt.

Fresenius stock closed at EUR 76.42 on Xetra on September 24, 2026, down 0.4 percent from the previous session. European shares also moved lower as markets weighed Middle East tensions and awaited US-China talks, according to Reuters.

September 24, 2026 in numbers

Fresenius SE (ISIN DE0005785604) traded between EUR 75.98 and EUR 76.88 on Xetra, with a closing price of EUR 76.42. The DAX closed at 23,642.11 points, down 0.5 percent on September 24, 2026, leaving Fresenius 0.1 percentage point ahead of the reference index.

September 25, 2026 events

German consumer confidence data are scheduled for release on September 25, 2026, while euro area money-supply data and US durable-goods orders are also due. The agenda published by Aktiencheck lists the US Michigan sentiment index among the later economic releases.

Disclaimer...

en | DE0005785604 | FRESENIUS | boerse | 70181547 | bgmi